Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Psychiatriki ; 30(4): 339-344, 2019.
Article in English | MEDLINE | ID: mdl-32283537

ABSTRACT

The present paper is describing a case of persistent genital arousal disorder that developed to a 55-year-old woman, shortly after the initiation of zolpidem. Persistent genital arousal disorder (PGAD) is a clinical entity that appears with a relatively low frequency in women, and is characterized by persistent or recurrent, unwanted and bothersome feelings of genital arousal, which often do not resolve with orgasm and are not associated with sexual desire (sexual interest, thoughts or fantasies). Women who experience PGAD often have feelings of shame, guilt and distress. Although its exact etiology remains unclear, various etiological factors have been proposed, central or peripheral, which may be psychological, vascular, dietary, pharmacological or neurological. Additionally, its presence has been associated to restless legs syndrome and overactive bladder syndrome. Likewise, multiple therapeutic interventions have been proposed and tried in patients with PGAD, either pharmacological (SSRIs, SNRIs, antiandrogens, benzodiazepines, antipsychotics, anticonvulsive agents) or other (ECT, physiotherapy, psychotherapy, nerve stimulation). Zolpidem is a nonbenzodiazepine indirect GABA A receptor agonist, which has lately been used as a therapeutic agent for PGAD in some cases. Nevertheless, in our patient, receiving zolpidem for insomnia seemed to be timely connected to the onset of PGAD symptomatology. The aim of the present paper is to highlight the need for more research into the possible factors that may contribute to PGAD.


Subject(s)
Olanzapine/administration & dosage , Sexual Dysfunctions, Psychological , Sleep Initiation and Maintenance Disorders/drug therapy , Zolpidem , Antipsychotic Agents/administration & dosage , Female , GABA-A Receptor Agonists/administration & dosage , GABA-A Receptor Agonists/adverse effects , Humans , Middle Aged , Psychological Distress , Restless Legs Syndrome/diagnosis , Restless Legs Syndrome/etiology , Sexual Dysfunctions, Psychological/chemically induced , Sexual Dysfunctions, Psychological/physiopathology , Sexual Dysfunctions, Psychological/psychology , Sexual Dysfunctions, Psychological/therapy , Treatment Outcome , Withholding Treatment , Zolpidem/administration & dosage , Zolpidem/adverse effects
2.
Appl Radiat Isot ; 118: 18-24, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27571965

ABSTRACT

An X-ray dual energy (XRDE) method was examined, using polynomial nonlinear approximation of inverse functions for the determination of the bone Calcium-to-Phosphorus (Ca/P) mass ratio. Inverse fitting functions with the least-squares estimation were used, to determine calcium and phosphate thicknesses. The method was verified by measuring test bone phantoms with a dedicated dual energy system and compared with previously published dual energy data. The accuracy in the determination of the calcium and phosphate thicknesses improved with the polynomial nonlinear inverse function method, introduced in this work, (ranged from 1.4% to 6.2%), compared to the corresponding linear inverse function method (ranged from 1.4% to 19.5%).


Subject(s)
Absorptiometry, Photon/methods , Algorithms , Bone and Bones/chemistry , Calcium/analysis , Phosphorus/analysis , Radiographic Image Interpretation, Computer-Assisted/methods , Computer Simulation , Humans , Models, Statistical , Numerical Analysis, Computer-Assisted , Phantoms, Imaging , Reproducibility of Results , Sensitivity and Specificity
3.
Comput Math Methods Med ; 2015: 574238, 2015.
Article in English | MEDLINE | ID: mdl-26246848

ABSTRACT

Dual energy methods can suppress the contrast between adipose and glandular tissues in the breast and therefore enhance the visibility of calcifications. In this study, a dual energy method based on analytical modeling was developed for the detection of minimum microcalcification thickness. To this aim, a modified radiographic X-ray unit was considered, in order to overcome the limited kVp range of mammographic units used in previous DE studies, combined with a high resolution CMOS sensor (pixel size of 22.5 µm) for improved resolution. Various filter materials were examined based on their K-absorption edge. Hydroxyapatite (HAp) was used to simulate microcalcifications. The contrast to noise ratio (CNR tc ) of the subtracted images was calculated for both monoenergetic and polyenergetic X-ray beams. The optimum monoenergetic pair was 23/58 keV for the low and high energy, respectively, resulting in a minimum detectable microcalcification thickness of 100 µm. In the polyenergetic X-ray study, the optimal spectral combination was 40/70 kVp filtered with 100 µm cadmium and 1000 µm copper, respectively. In this case, the minimum detectable microcalcification thickness was 150 µm. The proposed dual energy method provides improved microcalcification detectability in breast imaging with mean glandular dose values within acceptable levels.


Subject(s)
Breast/pathology , Mammography/methods , Adipose Tissue/pathology , Algorithms , Breast Density , Breast Neoplasms , Calcinosis , Computer Simulation , Durapatite/chemistry , Female , Humans , Mammary Glands, Human/abnormalities , Phantoms, Imaging , Radiographic Image Interpretation, Computer-Assisted/methods , Reproducibility of Results , Signal-To-Noise Ratio , X-Rays
4.
Phys Med ; 31(3): 307-13, 2015 May.
Article in English | MEDLINE | ID: mdl-25726476

ABSTRACT

Non-invasive dual energy methods have been used extensively on osteoporosis diagnosis estimating parameters, such as, Bone Mineral Density (BMD) and Bone Mineral Content (BMC). In this study, an X-ray dual energy method (XRDE) was developed for the estimation of the bone Calcium-to-Phosphorous (Ca/P) mass ratio, as a bone quality index. The optimized irradiation parameters were assessed by performing analytical model simulations. X-ray tube output, filter material and thickness were used as input parameters. A single exposure technique, combined with K-edge filtering, was applied. The optimal X-ray spectra were selected according to the resulted precision and accuracy values. Experimental evaluation was performed on an XRDE system incorporating a Cadmium Telluride (CdTe) photon counting detector and three bone phantoms with different nominal mass Ca/P ratios. Additionally, the phantoms' mass Ca/P ratios were validated with energy-dispersive X-ray spectroscopy (EDX). Simulation results showed that the optimum filter atomic number (Z) ranges between 57 and 70. The optimum spectrum was obtained at 100 kVp, filtered with Cerium (Ce), with a surface density of 0.88 g/cm(2). All Ca/P ratio measurements were found to be accurate to within 1.6% of the nominal values, while the precision ranged between 0.91 and 1.37%. The accuracy and precision values of the proposed non-invasive method contributes to the assessment of the bone quality state through the mass Ca/P ratio determination.


Subject(s)
Absorptiometry, Photon , Bone and Bones/metabolism , Calcium/metabolism , Phosphorus/metabolism , Bone Density , Bone and Bones/physiology , Cadmium Compounds , Humans , Osteoporosis/diagnosis , Phantoms, Imaging , Tellurium
5.
Cell Death Differ ; 20(3): 490-502, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23197296

ABSTRACT

Unrepaired DNA double-strand breaks (DSBs) cause genetic instability that leads to malignant transformation or cell death. Cells respond to DSBs with the ordered recruitment of signaling and repair proteins to the sites of DNA lesions. Coordinated protein SUMOylation and ubiquitylation have crucial roles in regulating the dynamic assembly of protein complexes at these sites. However, how SUMOylation influences protein ubiquitylation at DSBs is poorly understood. We show herein that Rnf4, an E3 ubiquitin ligase that targets SUMO-modified proteins, accumulates in DSB repair foci and is required for both homologous recombination (HR) and non-homologous end joining repair. To establish a link between Rnf4 and the DNA damage response (DDR) in vivo, we generated an Rnf4 allelic series in mice. We show that Rnf4-deficiency causes persistent ionizing radiation-induced DNA damage and signaling, and that Rnf4-deficient cells and mice exhibit increased sensitivity to genotoxic stress. Mechanistically, we show that Rnf4 targets SUMOylated MDC1 and SUMOylated BRCA1, and is required for the loading of Rad51, an enzyme required for HR repair, onto sites of DNA damage. Similarly to inactivating mutations in other key regulators of HR repair, Rnf4 deficiency leads to age-dependent impairment in spermatogenesis. These findings identify Rnf4 as a critical component of the DDR in vivo and support the possibility that Rnf4 controls protein localization at DNA damage sites by integrating SUMOylation and ubiquitylation events.


Subject(s)
DNA Repair , Nuclear Proteins/metabolism , Transcription Factors/metabolism , Adaptor Proteins, Signal Transducing , Alleles , Animals , BRCA1 Protein/metabolism , Cell Cycle Proteins , Cell Line , DNA Breaks, Double-Stranded , Genotype , Intracellular Signaling Peptides and Proteins/metabolism , Mice , Mice, Transgenic , Nuclear Proteins/genetics , Rad51 Recombinase/metabolism , Radiation, Ionizing , Sumoylation , Transcription Factors/genetics , Ubiquitin-Protein Ligases , Ubiquitination
6.
Eur J Contracept Reprod Health Care ; 9(1): 47-51, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15352695

ABSTRACT

AIMS: The study was set up to analyze the psychological/emotional needs of women who undergo treatment for in vitro fertilization (IVF) and to emphasize the importance of the psychosocial support that family planning centers can provide to them. METHOD: This was a cohort study with closed questions. A total of 235 infertile women participating in an IVF program were studied. The statistical analysis of the findings was conducted by the Statistical Package for Social Sciences. RESULTS: The psychosocial support and the scientific information provided to those women who participate in IVF programs are insufficient. In order to succeed in an IVF program, the women must be assisted by a doctor with much medical experience. The study shows that 59.3% of the women studied sought more medical information and another 32.5% sought emotional support. These percentages varied with reference to education, age and origin. These kinds of services must be provided by family planning centers.


Subject(s)
Counseling , Family Planning Services , Fertilization in Vitro/psychology , Infertility, Female/psychology , Social Support , Stress, Psychological/etiology , Adult , Educational Status , Female , Greece , Humans , Surveys and Questionnaires
7.
Br J Cancer ; 89(6): 1055-61, 2003 Sep 15.
Article in English | MEDLINE | ID: mdl-12966425

ABSTRACT

HER-2/neu oncoprotein contains several major histocompatibility complex class I-restricted epitopes, which are recognised by cytotoxic T lymphocyte (CTL) on autologous tumours and therefore can be used in immune-based cancer therapies. Of these, the most extensively studied is HER-2(9(369)). In the present report, we used dendritic cells pulsed with HER-2(9(369)) to stimulate, in the presence of IL-7 and IL-12, the production of IFN-gamma by patients' CTL detected by the enzyme-linked immunosorbent spot-assay. Frequencies of peptide-specific precursors were estimated in HLA-A2, HLA-A3 and HLA-A26 patients with HER-2/neu-positive (+) breast, ovarian, lung, colorectal and prostate cancers and healthy individuals. We found increased percentages of such precursors in HLA-A2 (25%) and HLA-A26 (30%) patients, which were significantly higher (60%) in HLA-A3 patients. Our results demonstrate for the first time that pre-existing immunity to HER-2(9(369)) occurs in patients with colorectal, lung and prostate cancer. They also suggest that HER-2(9(369)) can be recognised by CTL, besides HLA-A2, also in the context of HLA-A3 and HLA-A26, thus increasing the applicability of HER-2(9(369))-based vaccinations in a considerably broader patients' population.


Subject(s)
Dendritic Cells/immunology , Neoplasms/immunology , Peptide Fragments/immunology , Receptor, ErbB-2/metabolism , T-Lymphocytes, Cytotoxic/immunology , Adult , Aged , Cell Division , Cytokines/metabolism , Dose-Response Relationship, Immunologic , Enzyme-Linked Immunosorbent Assay , Female , HLA-A Antigens/immunology , HLA-A2 Antigen/immunology , HLA-A3 Antigen/immunology , Humans , Immunization , Immunophenotyping , Interferon-gamma/biosynthesis , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Male , Middle Aged
8.
Br J Cancer ; 85(10): 1527-34, 2001 Nov 16.
Article in English | MEDLINE | ID: mdl-11720440

ABSTRACT

HER2/neu-derived peptides inducing MHC class II-restricted CD4+ T helper lymphocyte (Th) responses, although critical for tumour rejection, are not thoroughly characterized. Here, we report the generation and characterization of CD4+ T cell clones specifically recognizing a HER-2/neu-derived peptide (776-788) [designated HER2(776-788)]. Such clones yielded specific proliferative and cytokine [gamma-interferon(IFN)-gamma] responses when challenged with autologous dendritic cells (DCs) loaded with HER2(776-788). By performing blocking studies with monoclonal antibodies (MAbs) and by using DCs from allogeneic donors sharing certain HLA-DR alleles, we found that HER2(776-788) is a promiscuous peptide presented, at least, by DRB5*0101, DRB1*0701 and DRB1*0405 alleles. One TCRV beta 6.7+ clone recognized the HLA-DRB5*0101+ FM3 melanoma cell line transfected with a full length HER-2/neu cDNA. Moreover, this clone recognized the HER-2/neu+ SKBR3 breast cancer cell line induced to express HLA-DR, thus demonstrating that HER2(776-788) represents a naturally processed and presented epitope. Our data demonstrate that helper peptide HER2(776-788) represents a promiscuous epitope binding to at least three HLA-DR alleles, thus offering a broad population coverage. The use of antigenic peptides presented by major histocompatibility complex (MHC) class II in addition to those presented by class I may improve the therapeutic efficacy of active immunization.


Subject(s)
Antigen Presentation , Antigens, Neoplasm/immunology , Epitopes, T-Lymphocyte/immunology , HLA-DR Antigens/physiology , Peptide Fragments/immunology , Receptor, ErbB-2/immunology , T-Lymphocytes, Cytotoxic/immunology , Cell Line , Cells, Cultured , Clone Cells , Humans , Interferon-gamma/biosynthesis , Lymphocyte Activation , Neoplasms/immunology , Peptides/immunology , Tumor Cells, Cultured
9.
Hepatogastroenterology ; 46(25): 148-56, 1999.
Article in English | MEDLINE | ID: mdl-10228780

ABSTRACT

BACKGROUND/AIMS: The successful management of metastatic melanoma is mostly relevant to the feasibility of a sustained immunostimulation requiring high doses of interleukin-2 (IL-2). Sustained immune response is initiated, in terms of cellular and humoral immunity, persisting for 15 days following the end of exogenous IL-2 transplenic administration. METHODOLOGY: We proceed to the transplenic immunostimulation using IL-2 suspended in lipiodolurografin emulsion through an arterial catheter, which is introduced into the splenic artery through laparotomy for the management of patients with advanced metastatic melanoma. Eligible for our study were 19 patients undergoing transplenic immunostimulation and locoregional or systemic chemotherapy, in relation to the site of the disease. In cases of metastatic liver melanoma, transtumoral immunostimulation was also carried out. RESULTS: Complete response to the regimen, partial response, stable disease and progressive disease were observed in 21%, 42%, 16%, and 21%, respectively. CONCLUSIONS: Transplenic immunostimulation has promising potentials in metastatic melanoma patients, on the basis of present results.


Subject(s)
Immunization , Interleukin-2/therapeutic use , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Lung Neoplasms/secondary , Lung Neoplasms/therapy , Melanoma/secondary , Melanoma/therapy , Combined Modality Therapy , Disease Progression , Female , Humans , Interferon-gamma/therapeutic use , Interleukin-2/administration & dosage , Lymphatic Metastasis , Male , Melanoma/pathology , Splenic Artery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...